Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
10/2003
10/30/2003US20030202969 Enhancing therapeutic effectiveness of nitric oxide inhalation
10/30/2003US20030202957 Aqueous mixture of salt and polyoxyethylene glycol; laxative
10/30/2003US20030202939 Forming oxygen free radicals; destroying tumor, cancer
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482439A1 Use of topical compositions for the control of microbial diseases of the nail
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2481972A1 Methods of treating ileus
10/30/2003CA2481786A1 Methods of treating necrotizing enterocolitis
10/30/2003CA2481524A1 Method of inhibiting restenosis
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/30/2003CA2481088A1 Use of materials having zinc ionophoric behavior
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1355665A2 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
10/29/2003EP1011692B1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY
10/29/2003CN1452596A Method and apparatus for producing high functional water contg. titanium
10/29/2003CN1452499A Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
10/29/2003CN1451430A Medicine composition for treating ischemic necrosis of femur head and preparing process thereof
10/29/2003CN1451392A Antihyperlipidemia active carbon capsule
10/29/2003CN1451391A Medicine for treating dermatopathy
10/29/2003CN1125650C Human immunization strengthening medicine
10/29/2003CN1125645C Ointment for treating psoriasis
10/29/2003CN1125644C Ointment for treating acne
10/29/2003CN1125643C External use medicine for treating psoriasis
10/29/2003CN1125641C Hongkong foot treating ointment
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638915 Anti-viral composition
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638539 Trace elements
10/28/2003US6638521 Oral liquid mucoadhesive compositions
10/23/2003WO2003087308A2 Use of interleukin-24 to treat ovarian cancer
10/23/2003WO2003087307A2 Use of interleukin-19 to treat cervical cancer
10/23/2003WO2003087164A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003WO2003086973A1 Process and apparatus for use in preparing an aqueous magnesium bicarbonate solution
10/23/2003WO2003086427A1 Topical formulation for dredging or interupting milk without pain and its process
10/23/2003WO2003086424A1 Pharmaceutical composition comprising arsenite for the treatment of malignancy
10/23/2003WO2003086423A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086321A2 Modified release minerals
10/23/2003WO2003086302A2 Propagermanium for treating myeloma bone disease and other bone disorders
10/23/2003WO2003086298A2 Use of interleukin-19 to treat ovarian cancer
10/23/2003WO2003086080A1 Method and composition for improving fertility health in female and male animals and humans
10/23/2003WO2003086078A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003US20030199535 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
10/23/2003US20030199430 Zinc compounds such as zinc gluconate, zinc acetate, or zinc citrate; and glycine, leucine, isoleucine, lysine, valine or isovaline
10/23/2003US20030199424 of a neuropathic condition, by administering anangiotensin II receptor I (AT1 receptor) antagonists
10/23/2003US20030198695 Herbo-mineral composition
10/23/2003US20030198692 Red algae extract; human, veterinary medicine; mixture of cell permeability agent and microbiocide
10/23/2003US20030198691 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
10/23/2003US20030198690 Administering zinc using stent; antiproliferative agent
10/23/2003US20030198689 Nontoxic aqueous solution; electrolysis; bactericide, viricide
10/23/2003CA2481603A1 Method and composition for improving fertility health in female and male animals and humans
10/23/2003CA2480882A1 Low-dose potassium supplementation for the prevention and treatment of hypertension
10/23/2003CA2480512A1 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium
10/23/2003CA2480365A1 Iron dextrin compounds for the treatment of iron deficiency anaemia
10/23/2003CA2480213A1 Use of interleukin-19 to treat ovarian cancer
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2479519A1 Use of interleukin-19 to treat cervical cancer
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354607A1 Solution for peritoneal dialysis and two-chambers bag therefor
10/22/2003EP1354516A1 Multi-purpose acid compositions
10/22/2003EP1353932A1 Compositions containing a ruthenium(iii) complex and a heterocycle
10/22/2003EP1353693A2 Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer
10/22/2003EP1353679A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1154781B1 Preparation for regulating lower bowel function
10/22/2003EP0929293B1 Liposomes containing a cisplatin compound
10/22/2003CN1450914A Preparation of aqueous clear solution dosage forms with bile acids
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1449819A Weishengli oral liquid medicine and preparation process thereof
10/22/2003CN1449815A Medicine for treating inflammation
10/22/2003CN1449768A Nano Selenium-calcium compound and preparation process thereof
10/22/2003CN1449767A Painless milkphobic and weaning preparation for external use
10/22/2003CN1449746A Soft capsule containing trace element
10/21/2003US6635676 Non-toxic antimicrobial compositions and methods of use
10/21/2003US6635628 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
10/21/2003US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/16/2003WO2003084552A1 Composition for the topical treatment of vulvovaginitis and mycoses
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003068247B1 Eye installation based on iodine anions
10/16/2003WO2003015707A3 Method for treating lung cancers
10/16/2003WO2002094745A3 Non-peptidic cyclophilin binding compounds and their use
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002045705A3 Regenaration of blood vessels
10/16/2003US20030195165 Comprises arginine as nitric oxide donor; synergistic; contains no adenosine and/or linsidomine
10/16/2003US20030194448 Oral rehydration composition
10/16/2003US20030194447 Antiseptic compositions and methods
10/16/2003US20030194446 Zinc oxide compositions for dermatheraputics
10/16/2003US20030194444 Methods of treating skin and integument conditions
10/16/2003US20030194390 Alkyl cyanoacrylate and inhibitor and aggregate structure formed; alkyl fatty ester, opacifier; ablating tissue by blocking blood flow
10/16/2003CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/15/2003EP1351887A2 Process for the rehydration of magaldrate powder
10/15/2003EP1351697A2 Pharmaceutical for stimulating the regeneration of tissues
10/15/2003EP1351677A2 Method for treating cancer
10/15/2003EP1351675A2 Alpha-difluoromethylornithine (dfmo) use in the human prostate
10/15/2003EP1351573A1 Methods for modulating tumor growth and metastasis
10/15/2003EP1007096B1 Arginine silicate inositol complex and use thereof
10/15/2003EP0874558B1 Liquid oral compositions comprising a calcium compound and an acidulant
10/15/2003EP0859813B1 Bioactive composite material for repair of hard and soft tissues
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 563